Key Points
-
Despite the long-term decline in cigarette consumption, Altria remains very profitable and a cash-generating machine.
-
It’s renowned as a Dividend King.
-
One of the great dividends of our age is paid by a company making products so unfashionable they’re barely visible anymore. I’m talking about Altria (NYSE:MO), the latest iteration of a storied tobacco enterprise that created and still sells the iconic Marlboro brand in this country.
Several decades ago, it was rare to visit a household, office, or restaurant where at least one occupant wasn’t lighting up. These days, it’s normal to go days, weeks, even months without encountering any smokers. The cigarettes that remain the hard core of Altria’s production to this day aren’t a growing market. So it’s worthwhile to explore whether the company’s famously high-yield dividend — which currently pays out at 5.6% — is sustainable for much longer. Here’s my take on that.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same “Total Conviction” signal is flashing for a company 1/100th the size of Nvidia. Continue »
Image source: Getty Images.
Unloved but appreciated
Given the many restrictions on traditional tobacco consumption in the U.S., plus the increasing health consciousness of its population, it’s a wonder Altria ekes out any growth at all. In the company’s third quarter, its net revenue only crept up by 1% year over year to $6.13 billion. If we strip excise (or “sin”) taxes out of the equation, we get a meatier growth figure of 3.6%, with revenue net of such obligations of $5.44 billion. But that improvement was largely due to price increases, as total shipment volume of smokeables sank by 2.9%.
Revenue net of excise taxes, by the way, is considered the yardstick top-line figure for tobacco companies, so I’ll stay with that throughout this piece without repeating the descriptor.
Of that $5.44 billion, smokeable products — anchored by Marlboro — pulled in $4.76 billion, or 88% of the total. Almost all of the remainder ($667 million) consisted of oral tobacco products, the revenue for which rose only marginally during the period. There’s one bright spot there, however, and that’s the company’s promising on! and on! PLUS nicotine pouches, which collectively experienced a 13% increase in shipment volume.
Years ago, Altria sensibly tried to pivot toward products with a brighter future, specifically next-generation tobacco offerings seen as more innovative and (relatively) healthier. But its attempts to develop a vape in-house flopped, as did its acquisitions of stakes in existing vape manufacturers (most notably the spectacular flameout of the once-promising Juul Labs). These days, the company’s “all other” category covers the tiny sales of such goods, which amounted to $12 million in the quarter.
Low costs and high margins
Non-GAAP (adjusted) profitability, like revenue, didn’t bounce sharply higher for Altria. It improved by 4% to $2.55 billion in the quarter. This, however, makes for a sky-high net margin of 47%. Most companies would be satisfied with a percentage in the low double digits. What’s the secret sauce with Altria?
It’s about the core product. Cigarettes are addictive, so users not only come back time and again to buy them, but they’re also willing to put up with the frequent price raises by makers like Altria (and to fork over the always-high excise taxes to boot). Given that, there’s little or no reason for a manufacturer to innovate the product, and to top it all off, cigarettes are cheap to make.
Put all of this together, and you have a good that generates high profits at very modest and steady costs. That’s why, even in this day and age, tobacco companies continue to be cash-generating machines. Altria’s statement of cash flows is always a thing of beauty, with high operating flows and tiny investments resulting in a mighty gush of free cash flow (FCF). This was only slightly down year over year in the third quarter, to almost $3 billion. That’s far more than the under $1.8 billion the company needed to fund that high-yield dividend, plus stock-boosting share repurchases totaling $400 million.
The ever-bulging coffers
American smokers aren’t going to change their habits much, so Altria felt confident enough to raise its full-year 2026 earnings guidance. Adjusted net income should rise by 4.5% to 6% over the 2025 figure to $5.66 to $5.74 per share, the company believes. All that cash flow has to go somewhere, so the company’s board authorized a $1 billion expansion of its existing share repurchase program, which had $265 million remaining. The initiative has also been extended, with the new deadline being Dec. 31, 2027.
Both of these moves strongly indicate Altria will keep its now 57-year (!) dividend raise streak alive, maintaining its status as a Dividend King (one of the few stocks that have raised their payout for at least 50 consecutive years). After all, its payout is one of the stock’s great draws, and management is acutely aware of its importance. I predict, with the same level of confidence as Altria’s leaders announced the guidance raise and the share buyback news, that it’ll continue to deliver those high-margin profits and impressive levels of FCF.
And with that, this perpetually high-yield dividend is extremely safe, in my opinion.
Should you buy stock in Altria Group right now?
Before you buy stock in Altria Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Altria Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $315,271!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $896,981!*
Now, it’s worth noting Stock Advisor’s total average return is 768% — a market-crushing outperformance compared to 198% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of November 20, 2026.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.